Progression to AIDS and death and response to HAART in men and women from a multicenter hospital-based cohort

Journal of Women's Health

Volumn 16, Issue 7, 2007, Pages 1052-1061

  Perez Hoyos, Santiago ^a   Rodríguez Arenas, M Ángeles ^b   De La Hera, Manuela García ^b   Iribarren, José A ^c   Moreno, Santiago ^d   Vaciana, Pompeyo ^e   Peña, Alejandro ^f   Gómez Sirvent, José L ^g   Saumoy, María ^h   Lacruz, José ⁱ   Padilla, Sergio ^j   Oteo, José A ^k   Asencio, Román ^e   Del Amo, Julia ^b,l  

^a Generalitat Valenciana   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^g HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^h HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

ⁱ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^k Hospital de La Rioja   (Spain)

^l CARLOS III INSTITUTE OF HEALTH   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DEATH; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SEX DIFFERENCE; SPAIN; SURVIVAL RATE; VIRUS LOAD;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SEX DISTRIBUTION; SPAIN; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 34748915969     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2007.0437     Document Type: Article

References (29)

1. Prins M, Meyer L, Hessol NA. Sex and the course of HIV infection in the pre- and highly active antiretroviral therapy eras. AIDS 2005;19:357.
2. Lemp GP, Hirozawa AM, Cohen JB, Derich PA, Hernandez SR. Survival for women and men with AIDS. J Infect Dis 1992;166:74.
3. Melnick S, Sherer R, Louis T, et al. Survival and disease progression according to gender of patients with HIV infection: The Terry Beirn community programs for clinical research on AIDS. JAMA 1994;272:1915.
4. Phillips AN, Antunes F, Stergious G, et al. A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS 1994;8:831.
5. Hubert JB, Rouzioux C, Boufassa F, Delfraissy JF, Meyer L. Gender, disease progression and response to HAART. XVI International Conference on HIV/AIDS. Barcelona, 2002. ThOrC1448.
6. CASCADE collaboration. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet 2003;362:1267.
7. Madec Y, Boufassa F, Porter K, Meyer L, on behalf of CASCADE collaboration. Spontaneous control of viral load and CD4 progression among HIV-1 seroconverters in CASCADE. AIDS 2005;19:2001.
8. GEMES. El periodo de incubación del SIDA en España antes de la terapia HAART. Med Clin 2000;115:681.
9. Pérez-Hoyos S, Del Amo J, Muga R, et al., and GEMES. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV Seroconverters: Differences by transmission category. AIDS 2003;17:353.
10. Garcia de la Hera M, Ferreros I, Del Arno J, et al. Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of intravenous dug users from 1986 to 2001. J Epidemiol Community Health 2004;58:944.
11. Sterling TR, Vlahov D, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720.
12. Farzadegan H, Hoover DR, Astemborski J, et al. Sex diferences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510.
13. Napravnik S, Poole C, Thomas JC, Eron JJ. Gender difference in HIV RNA levels: A meta-analysis of published studies. J Acquir Immune Defic Syndr 2002;31:11.
14. Prins M, Robertson JR, Brettle RP, et al. Do gender differences in CD4 counts matter? AIDS 1999;13:2361.
15. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998;352:1725.
16. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 2001;338:853.
17. Davidson AJ, Bertram SL, Lezotte DC, et al. Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men. Med Care 1998;36:1676.
18. Hellinger FJ. The use of health services by women with HIV infection. Health Serv Res 1993;28:543.
19. Dray-Spira R, Lert F. Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy. AIDS 2003;17:283.
20. García de la Hera M, Ruiz I, Pérez-Hoyos S, Hernández-Aguado I. Health services utilization according to gender in a cohort of intravenous drug users infected with HIV. Med Clin (Barc) 2003;120:489.
21. Moore AL, Mocroft A, Madge S, et al. Gender differences in virologic response to treatment in an HIV-positive population: A cohort study. J Acquir Immune Defic Syndr 2001;26:159.
22. Nicastri E, Angeletti Cl, Palmisano L, et al., Italian Antiretroviral Treatment Group. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005;19:577.
23. Muga R, Roca J, Egea JM, et al. Mortality of HIV-positive and HIV-negative heroin abusers as a function of duration of injecting drug use. J Acquir Immune Defic Syndr 2000,23:332.
24. Jarrin I, Lumbreras B, Pérez-Hoyos S, Hurtado I, Hernández-Aguado I. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART. Int J Epidemiol 2007;36:187.
25. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004;19:1111.
26. Giordano TP, Wright JA, Hasan MQ, Clinton WA, Graviss EA, Visnegarwala F. Do sex and race/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy? Clin Infect Dis 2003;37:433.
27. Sterling TR, Chaisson RE, Moore RD. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active retroviral therapy. AIDS 2001;15:2251.
28. Moore AL, Kirk O, Johnson AM, et al. Virologic, immunologic, and clinical response to highly active antiretroviral therapy: The gender issue revisited. J Acquir Immune Defic Syndr 2003;32:452.
29. Waldron I. Recent trends in sex mortality ratios for adults in developed countries. Soc Sci Med 1993;36:451.